You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 10, October 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Symptom Management in Multiple Sclerosis, 3rd edition

edited by Randall T. Schapiro, MD, 204 pp, with illus, $19.95, ISBN 1888799226, New York, NY, Demos Medical Publishing Inc, 1998.

Arch Neurol. 1999;56:1297-1298.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The focus of this book is to provide patients with multiple sclerosis (MS) and their families, friends, and health care professionals with guidance for the care of patients with MS. The book is divided into 3 sections.

Part I, "What Is Multiple Sclerosis?" includes 3 chapters. Chapter 1, "Multiple Sclerosis Is . . . ," describes the disease in layman's terms. It is well written, clear, and concise. Topics include the anatomy of the disease, myelin, demyelination, MS characteristics and classification of disease, the immune system, and possible causes of MS. Chapter 2, "The Management of MS," describes how to choose a physician, the importance of working with an MS specialist, and the role of alternative medicine in the treatment of MS. Chapter 3, "Management of the Disease Process," briefly describes the role of the new immunomodulating therapies (Avonex [interferon beta-1a], Betaseron [interferon beta-1b], and Copaxone [glatiramer acetate]) that are . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.